A Phase I Study of TAS-114 in Healthy Adult Male Subjects
Phase 1
- Conditions
- Healthy Adult Male Subjects
- Registration Number
- JPRN-jRCT2080221521
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 35
Inclusion Criteria
Healthy male subject who have given written informed consent
- Subject's age of twenty years old or more and less than forty years old
- Subject's weight of 50.0kg or more and BMI (Body Mass Index) of 18.0-25.0kg/m2
Exclusion Criteria
- Subject with a history or concurrent status of allergic reaction
- Subject with a history or concurrent status of alcoholic or drug addiction
- Subject who is not willing to stop smoking during hospitalization
- Subject who recieved other investigational drug within 180 days before receiving the study drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety, Pharmacokinetics<br>CTCAE (ver.4.0)
- Secondary Outcome Measures
Name Time Method